HAYW vs JAZZ · P/E 26, rev $1.12B vs P/E 1988, rev $2.28B
Hayward Holdings Inc (HAYW) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Hayward Holdings Inc (HAYW) is a electrical equipment & parts company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported HAYW revenue for 2025-12-31 was $1.12B. Net income was $151.6M. Revenue was up 6.7% from 2024-12-31 to 2025-12-31. HAYW currently screens at market cap $3.16B and trailing P/E 26.1.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
HAYW currently screens at market cap $3.16B and trailing P/E 26.1. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the HAYW and JAZZ stock pages for the full models.
Not investment advice.